SAB Biotherapeutics - 53 Year Dividend History | SABS
Historical dividend payout and yield for SAB Biotherapeutics (SABS) since 1971. The current TTM dividend payout for SAB Biotherapeutics (SABS) as of November 01, 2024 is $0.00. The current dividend yield for SAB Biotherapeutics as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.036B |
$0.002B |
|
SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
